BTG PLC (BTG.L)

BTG.L on London Stock Exchange

631.00GBp
28 Aug 2015
Change (% chg)

8.50p (+1.37%)
Prev Close
622.50p
Open
623.00p
Day's High
631.50p
Day's Low
616.50p
Volume
841,620
Avg. Vol
593,303
52-wk High
835.87p
52-wk Low
556.00p

BTG.L

Chart for BTG.L

About

BTG plc is a specialist healthcare company. The Company operates in three business segments: Interventional Medicine (IM) (oncology, vascular and pulmonology products), Specialty Pharmaceuticals (antidote products) and Licensing (royalties from licensed assets). The Company's Interventional Medicine segment offers a portfolio of... (more)

Overall

Beta: 0.60
Market Cap(Mil.): £2,383.02
Shares Outstanding(Mil.): 382.82
Dividend: --
Yield (%): --

Financials

  BTG.L Industry Sector
P/E (TTM): 67.76 35.33 35.49
EPS (TTM): 0.09 -- --
ROI: 4.32 15.34 14.80
ROE: 5.21 15.92 15.67
Search Stocks

BRIEF-BTG says Health Canada approves Varithena

* Health Canada has issued a notice of compliance approving Varithena

06 Aug 2015

Britain's BTG sees two-year build-up for varicose vein product

LONDON, May 19 - British pharmaceutical company BTG said its full-year profit was dampened by investment in new products, including its Varithena varicose veins treatment in the United States.

19 May 2015

BRIEF-BTG full-year profit dips on investments, acquisitions

* Fy pretax profit 26.7 million stg versus 33.3 million stg year ago

19 May 2015

British drugs firm BTG lifts 2014/15 sales forecast

LONDON, April 2 - British drugs company BTG nudged up its 2014/15 revenue forecast on Thursday and said it was on course for further strong growth in its new financial year.

02 Apr 2015

Earnings vs. Estimates

Search Stocks